Topic: Moderna

The death of actor James Van Der Beek from stage 3 colorectal cancer has renewed focus on the rising rates of the disease among adults under 50. Medical researchers are struggling to explain the increase in cases, while the FDA recently rejected Moderna's application for an mRNA-based flu vaccine. The segment emphasizes the importance of early screening and awareness.

A debate regarding the future of public health infrastructure centers on the Trump administration's reported decision to stop funding certain mRNA vaccine technology grants. Critics argue the public health system is being destroyed by a move toward "magic smoke and mirrors," while others contend that profitable corporations like Pfizer and Moderna should fund their own research rather than relying on government subsidies.

Dr. Robert Malone claims that the U.S. intelligence community, specifically the CIA, drove the rapid adoption of mRNA technology as a defense against germ warfare. The discussion suggests that the administrative state bypassed normal safety procedures because they viewed mRNA as the only viable "quick response" tool. The hosts also speculate on why media figures like Bill Maher have become vocal supporters of the technology.

Major news networks reported on the $500 million funding cut, highlighting that the targeted projects were led by Pfizer and Moderna. Critics question why profitable pharmaceutical giants require taxpayer subsidies for research. Dr. Celine Gounder appeared on CBS to defend mRNA technology as a vital tool for rapid pandemic response.

Dr. Marty Makary of the FDA discussed the agency's decision to restore access to a Sarepta gene therapy for muscular dystrophy despite safety signals. The conversation on CNBC also touched on the future of mRNA technology, with Makary suggesting it is a "powerful technology" for cancer vaccines. The hosts criticize the FDA's reliance on computational modeling over traditional randomized control trials.

A new Moderna vaccine named "Nex Spike" has drawn attention due to the Latin translation of "Nex" meaning death, though a Latin generator translates the full name as "don't." Meanwhile, a Netflix documentary titled "Pangolin: Kulu's Journey" aims to protect the endangered mammal. This shift in media portrayal is noted, as pangolins were previously blamed for the spread of COVID-19.

The Trump administration canceled a federal contract with Moderna intended to develop a vaccine for the H5N1 avian flu, which has affected over 1,000 cattle herds and 170 million birds. Dr. Vin Gupta and other infectious disease experts criticized the funding cut, warning that the virus is evolving rapidly as it spreads from birds to mammals like mountain lions. Critics of the administration's move argue that a "big terrible pandemic" is a matter of when, not if, despite the current strain's low contagiousness in humans.

A Moderna Human Resources executive revealed the use of GPT-based AI to create personality profiles of the company's executive committee. The AI is used to simulate scenarios, predict reactions to recommendations, and mediate interpersonal conflicts within the leadership team. This practice has raised concerns regarding the ethics and potential dangers of using artificial intelligence to analyze and manipulate human workplace dynamics.

The development of RNA vaccines by companies like Moderna and CureVac offered a potential path to beating the traditional 18-month timeline for vaccine creation. Experts noted the difficulty of ensuring efficacy in elderly populations and the risks of side effects when deployed at a global scale. Bill Gates mentioned that governments would need to provide risk indemnification before a vaccine could be distributed to the entire world.

Early data from Moderna's vaccine trials showed that 80% of participants experienced systemic side effects like chills and fevers after the second dose. Experts noted that most leading vaccine candidates would require two doses, creating a massive logistical challenge for manufacturing and public compliance. Ensuring that elderly populations are well-represented in trials was identified as a priority for gathering accurate safety data.

Moderna abruptly halted its mRNA vaccine clinical trial for Respiratory Syncytial Virus (RSV) in children after data indicated the vaccine might worsen the disease. The FDA disclosed that vaccinated children in the trial experienced severe RSV at rates up to three times higher than the placebo group.

The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna targeting current variants. Additionally, the federal government plans to relaunch the covidtest.gov website in late September, allowing households to order four free rapid test kits despite the hosts' skepticism regarding the ongoing necessity of these measures.

The U.S. government is funding Moderna to conduct human bird flu vaccine trials as H5N1 spreads among poultry and dairy cows. The USDA has mandated testing for lactating cows, and millions of chickens have been culled in Iowa. The hosts note that the public health risk remains low according to the CDC.

Moderna announced positive trial results for a combined COVID-19 and flu vaccine, aiming for federal approval by 2025. Dr. Ashish Jha appeared on Chris Cuomo's show to promote the shot, dismissing concerns about mRNA by stating it is naturally present in every cell of the body. The hosts criticize the "native ad" style of the reporting and express skepticism about vaccine safety.

The U.S. government is reportedly nearing an agreement to fund Moderna's bird flu vaccine trials, causing the company's stock to rise. The hosts suggest the push for bird flu awareness is a precursor to implementing mail-in voting or new masking mandates. They discuss the transition from traditional egg-based vaccine manufacturing to mRNA "platforms" or "operating systems."

A complex thesis suggests that COVID-19 was released to cover up a more deadly H7N9 avian flu outbreak that had been bubbling since 2013. The theory posits that "Operation Warp Speed" and the initial Moderna deal in January 2020 were actually targeting this avian flu rather than COVID-19. Documents related to "Crimson Contagion" are cited as evidence of a pre-planned Department of Defense response to a different viral threat.

The timeline of Operation Warp Speed is scrutinized, noting that Trump signed the Moderna deal on January 13, 2020, when only one death had been reported in China. This supports the theory that the administration was responding to an existing avian flu threat. Trump's insistence on using the term "China Virus" rather than COVID-19 is viewed as a deliberate distinction between the two pathogens.

Reports of a "mystery pneumonia" outbreak in Beijing and northern China have overwhelmed pediatric hospitals, drawing comparisons to the early days of COVID-19. Chinese authorities are reportedly blocking information as schools suspend classes. The hosts also play a clip of the Moderna CEO from a previous WEF meeting discussing the need to manufacture a billion doses in anticipation of a pandemic.

Archival clips from 2021 reveal that health officials chose not to update mRNA vaccines for the Delta variant primarily to avoid devaluing existing inventory and damaging public confidence. Despite the technology's "plug and play" marketing, officials pushed the original shots as "boosters" even as "breakthrough infections" became common. The strategy was described as a marketing game to move old stock rather than providing the most effective medical intervention.

The FDA authorized new COVID-19 booster shots from Pfizer and Moderna to target the latest strains, including the BA.2.86 variant. While national cases are not currently in a "worrisome wave," health officials are warning of a potential "winter wave." The discussion notes that the federal government will no longer pay for the shots, with costs shifting to private insurance and Medicare at approximately $120 per dose.